Results 151 to 160 of about 8,088 (248)

The effect of cisplatin on the role of proprotein convertases (PCs) in human ovarian cancer cells

, 2006
Hillary Michelle Boulay
openalex   +1 more source

Hemmstudien von rekombinant exprimiertem und gereinigtem Spodoptera frugiperda Furin mittels Peptidinhibitoren - Struktur- und Inhibitionseigenschaften der SFurin-Prodomäne [PDF]

, 2002
Prof. Dr. H. Kindl, Scheffczik, Hanno
core   +1 more source

Ramadan Intermittent Fasting Is Associated with Changes in Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Metabolically Healthy Obese Subjects [PDF]

, 2022
Hayder Hasan, Mohamed Madkour, Samir Awadallah, Mohamed Hassanein, Haitham Jahrami, MoezAlIslam E. Faris   +5 more
openalex   +1 more source

Proapelin is processed extracellularly in a cell line-dependent manner with clear modulation by proprotein convertases. [PDF]

Amino Acids, 2019
Shin K, Landsman M, Pelletier S, Alamri BN, Anini Y, Rainey JK.   +5 more
europepmc   +1 more source

Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Cell Surface Low-Density Lipoprotein Receptor [PDF]

, 2013
Hagai Tavori, Daping Fan, John Blakemore, Patricia G. Yancey, Lei Ding, MacRae F. Linton, Sergio Fazio   +6 more
openalex   +1 more source

Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study [PDF]

, 2017
Joshua Choi, Amir Khan, Michael Jarmin, Naila Goldenberg, Charles J. Glueck, Ping Wang   +5 more
openalex   +1 more source

Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. [PDF]

Mol Carcinog, 2017
Bassi DE, Zhang J, Renner C, Klein-Szanto AJ.   +3 more
europepmc   +1 more source

Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver

, 2020
Muhammad Shafiq, Timothy Walmann, Venkat Nutalapati, Cheryl Gibson, Yousaf Zafar   +4 more
openalex   +1 more source

Safety and Effectiveness of Alirocumab, a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor, in Patients With Familial or Non-Familial Hypercholesterolemia　― A Post-Marketing Survey (J-POSSIBLE) ―

, 2023
Arihiro Kiyosue, Satoshi Yasuda, Akiyoshi Tomura, Makiko Usami, Hidenori Arai   +4 more
openalex   +2 more sources

Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans. [PDF]

J Allergy Clin Immunol, 2017
Poposki JA, Klingler AI, Stevens WW, Peters AT, Hulse KE, Grammer LC, Schleimer RP, Welch KC, Smith SS, Sidle DM, Conley DB, Tan BK, Kern RC, Kato A.   +13 more
europepmc   +1 more source